Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241331 · ClinicalTrials.gov registry record · Phase 2
BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 233
- Enrollment target
NCT01241331 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 233 participants.
The verdict
NCT01241331, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 233 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.
Interventions
- DRUG Vehicle cream
- DRUG BLI1100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2010-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01241331
The ClinicalTrials.gov registry entry for NCT01241331 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle cream is the first listed.
NCT01241331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01241331 about?
NCT01241331 is a clinical study titled "BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris". The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.
What is the current status of trial NCT01241331?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 233 participants. The study started on 2010-11.
What interventions are being tested in trial NCT01241331?
The interventions under investigation include: Vehicle cream (DRUG), BLI1100 (DRUG).
Who is sponsoring clinical trial NCT01241331?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.